<VariationArchive RecordType="classified" VariationID="17263" VariationName="NM_000089.4(COL1A2):c.3279_3287del (p.1091PPG[3])" VariationType="Deletion" Accession="VCV000017263" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-20" DateCreated="2015-09-17" MostRecentSubmission="2015-09-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32302" VariationID="17263">
      <GeneList>
        <Gene Symbol="COL1A2" FullName="collagen type I alpha 2 chain" GeneID="1278" HGNC_ID="HGNC:2198" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94394895" stop="94431227" display_start="94394895" display_stop="94431227" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94023872" stop="94060543" display_start="94023872" display_stop="94060543" Strand="+" />
          </Location>
          <OMIM>120160</OMIM>
          <Haploinsufficiency last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000089.4(COL1A2):c.3279_3287del (p.1091PPG[3])</Name>
      <CanonicalSPDI>NC_000007.14:94427629:CCCCCTGGTCCCCCTGG:CCCCCTGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94427630" stop="94427638" display_start="94427630" display_stop="94427638" variantLength="9" positionVCF="94427629" referenceAlleleVCF="CCCCCCTGGT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94056942" stop="94056950" display_start="94056942" display_stop="94056950" variantLength="9" positionVCF="94056941" referenceAlleleVCF="CCCCCCTGGT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_2" sequenceAccession="LRG_2">
            <Expression>LRG_2:g.38078_38086del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_2t1" sequenceAccession="LRG_2t1">
            <Expression>LRG_2t1:c.3279_3287del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_2p1" sequenceAccession="LRG_2p1" change="p.1091_1093PPG[3]">
            <Expression>LRG_2p1:p.1091_1093PPG[3]</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.94056950_94056958del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.94056950_94056958del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.94427638_94427646del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.94427638_94427646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007405.1" sequenceAccession="NG_007405" sequenceVersion="1" change="g.38078_38086del">
            <Expression>NG_007405.1:g.38078_38086del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000089.4" sequenceAccession="NM_000089" sequenceVersion="4" change="c.3279_3287del" MANESelect="true">
            <Expression>NM_000089.4:c.3279_3287del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000080.2" sequenceAccession="NP_000080" sequenceVersion="2" change="p.1091PPG[3]">
            <Expression>NP_000080.2:p.1091PPG[3]</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257786" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="120160.0035" DB="OMIM" />
        <XRef Type="rs" ID="74315103" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000089.4(COL1A2):c.3279_3287del (p.1091PPG[3]) AND Osteogenesis imperfecta with normal sclerae, dominant form" Accession="RCV000018804" Version="29">
        <ClassifiedConditionList TraitSetID="5679">
          <ClassifiedCondition DB="MedGen" ID="C0268363">Osteogenesis imperfecta with normal sclerae, dominant form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-09-17" MostRecentSubmission="2015-09-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8786065</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5679" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3328" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta with normal sclerae, dominant form</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+4/5459" DB="Genetic Alliance" />
                <XRef ID="205497004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 4</ElementValue>
                <XRef ID="MONDO:0008148" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis Imperfecta Type IV</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OSTEOGENESIS IMPERFECTA, TYPE IV, WITH DENTINOGENESIS IMPERFECTA</ElementValue>
                <XRef Type="Allelic variant" ID="120160.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type IV</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI4</ElementValue>
                <XRef Type="MIM" ID="166220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8696" />
                <XRef ID="8696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <XRef ID="216820" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268363" DB="MedGen" />
              <XRef ID="MONDO:0008148" DB="MONDO" />
              <XRef Type="MIM" ID="166220" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39087" SubmissionDate="2015-09-15" DateLastUpdated="2015-09-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120160.0035_OSTEOGENESIS IMPERFECTA, TYPE IV" title="COL1A2, 9-BP DEL, NT3418_OSTEOGENESIS IMPERFECTA, TYPE IV" />
        <ClinVarAccession Accession="SCV000039087" DateUpdated="2015-09-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Lund et al. (1996) defined the molecular defect in COL1A2 in a family with type IV osteogenesis imperfecta (OI4; 166220) spanning 3 generations: the grandmother, a son and daughter of hers, and a daughter of the daughter. The color of the sclerae was normal. There were no signs of dentinogenesis imperfecta and hearing was normal. The grandmother was more mildly affected than her descendants; she was 168 cm tall and was fully mobile throughout her life, whereas the daughter and granddaughter were 146 cm and 148 cm tall, respectively, and walked with crutches. Sequencing of the COL1A2 gene indicated a 9-bp deletion of nucleotides 3418 to 3426, corresponding to the deletion of codons 1003 to 1006 of the gene and 3 amino acids, gly-pro-pro, of the protein.</Attribute>
              <Citation>
                <ID Source="PubMed">8786065</ID>
              </Citation>
              <XRef DB="OMIM" ID="166220" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A2" />
          </GeneList>
          <Name>COL1A2, 9-BP DEL, NT3418</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT3418</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120160.0035" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OSTEOGENESIS IMPERFECTA, TYPE IV</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39087" TraitType="Disease" MappingType="Name" MappingValue="OSTEOGENESIS IMPERFECTA, TYPE IV" MappingRef="Preferred">
        <MedGen CUI="C0268363" Name="Osteogenesis imperfecta with normal sclerae, dominant form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

